Fragile X Syndrome
Fragile X Syndrome
Fragile X Syndrome
GROUP: 7
X - chromosome
FMR-1 Gene
2 .The genetic code for the FMR-1 gene usually contains a limited
repetition of CGG sequences. The normal range is 5-50 repeats.
NORMAL
Repeats
5
50
CGG
FMR-1 Gene
200
PREMUTATION
FMR-1 Gene
CGG
4. If the number of repeats exceeds 200, usually this disrupts the code and
prevents the production of the FMR protein. These individuals have
the full mutation and usually are affected by fragile X syndrome.
200+
FULL MUTATION
FMR-1 Gene
CGG
X(Fragile) Y
Female carrier
X(Fragile) X
X (fragile )
X
X
X X(Fragile)
Normal Daughter
X
X(Fragile) Y
Son with fragile x
Normal Son
Diagnosis:
Any child with signs of developmental delay of speech, language, or
motor development with no known cause should be considered for
fragile X testing, especially if there is a family history of the condition.
Behavioral and developmental problems may indicate fragile X
syndrome, particularly if there is a family history of mental retardation.
Definitive identification of the fragile X syndrome is made by means of
a genetic test to assess the number of CGG sequence repeats in the
FMR-1 gene. Individuals with the premutation or full mutation may
be identified through genetic testing. Genetic testing for the fragile X
mutation can be done on the developing baby before birth through
amniocentesis or chorionic villus sampling (CVS), and is 99% effective
in detecting the condition due to trinucleotide repeat expansion.
Prenatal testing should only be undertaken after the fragile X carrier
status of the parents has been confirmed and the couple has been
counseled regarding the risks of recurrence. While prenatal testing is
possible to do with CVS, the results can be difficult to interpret and
additional testing may be required.
TREATMENT:
The End